SuperworthQuest Diagnostics profit margin DGX
Gross, operating and net profit as a share of revenue over the last twelve months, from 2009.
- Net margin, 12 months
- 9.5%
- Operating margin, 12 months
- 14.6%
- Net margin on a year earlier
- +0.6 pts
- Peer median
- 13.1%
Over the twelve months to Sep 30, 2026, Quest Diagnostics kept 9.5% of its revenue as net profit, with an operating margin of 14.6% and a gross margin of 33.1%.
Five years earlier its net margin was 19.8%.
The median for 10 diagnostics and research stocks of a similar size is 13.1%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | 9.0% | 14.1% | 33.2% |
| FY2024 | 8.8% | 13.6% | 32.9% |
| FY2023 | 9.2% | 13.6% | 33.0% |
| FY2022 | 9.6% | 14.4% | 34.7% |
| FY2021 | 18.5% | 22.1% | 39.0% |
| FY2020 | 15.2% | 20.9% | 38.5% |
| FY2019 | 11.1% | 15.9% | 34.8% |
| FY2018 | 9.8% | 14.6% | 34.6% |
| FY2017 | 10.4% | 15.7% | 36.2% |
| FY2016 | 8.6% | 17.0% | 38.6% |
| FY2015 | 9.5% | 18.7% | 37.8% |
| FY2014 | 7.5% | 13.2% | 37.6% |
| FY2013 | 11.9% | 20.6% | 39.4% |
| FY2012 | 7.5% | 16.3% | 40.9% |
| FY2011 | 6.4% | 13.3% | 42.1% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q3 FY26 | 9.5% | +0.6 pts | 14.6% | |
| Q2 FY26 | 9.2% | +0.2 pts | 14.1% | |
| Q1 FY26 | 9.1% | +0.2 pts | 14.3% | |
| Q4 FY25 | 9.0% | +0.2 pts | 14.1% | |
| Q3 FY25 | 8.9% | +0.1 pts | 14.1% | |
| Q2 FY25 | 9.0% | +0.0 pts | 14.0% | |
| Q1 FY25 | 8.8% | −0.3 pts | 13.7% | |
| Q4 FY24 | 8.8% | −0.4 pts | 13.6% | |
| Q3 FY24 | 8.8% | +0.6 pts | 13.1% | |
| Q2 FY24 | 9.0% | +0.6 pts | 13.5% | |
| Q1 FY24 | 9.1% | +0.9 pts | 13.5% | |
| Q4 FY23 | 9.2% | −0.3 pts | 13.6% |
Against its peers
Companies in Medical - Diagnostics & Research nearest Quest Diagnostics' size, closest first, today.
| Company | Profit margin |
|---|---|
| DGXQuest Diagnostics | 9.2% |
| LHLabcorp | 7.0% |
| MTDMettler-Toledo International | 21.9% |
| MEDPMedpace | 17.7% |
| RVTYRevvity | 8.2% |
| ILMNIllumina | 18.4% |
| IDXXIDEXX Laboratories | 25.0% |
| WATWaters | 3.6% |
| IQVIQVIA | 8.1% |
| AAgilent Technologies | 19.5% |
| BIOBio-Rad Laboratories | 8.6% |
| Peer median | 13.1% |
Where Quest Diagnostics ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Quest Diagnostics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.